Artia Global Partners LP Charles River Laboratories International, Inc. Transaction History
Artia Global Partners LP
- $367 Billion
- Q3 2024
A detailed history of Artia Global Partners LP transactions in Charles River Laboratories International, Inc. stock. As of the latest transaction made, Artia Global Partners LP holds 6,305 shares of CRL stock, worth $1.17 Million. This represents 0.34% of its overall portfolio holdings.
Number of Shares
6,305
Previous 6,905
8.69%
Holding current value
$1.17 Million
Previous $1.43 Billion
12.94%
% of portfolio
0.34%
Previous 0.28%
Shares
2 transactions
Others Institutions Holding CRL
# of Institutions
695Shares Held
52.2MCall Options Held
259KPut Options Held
463K-
Vanguard Group Inc Valley Forge, PA6.1MShares$1.13 Billion0.02% of portfolio
-
Black Rock Inc. New York, NY5.09MShares$945 Million0.02% of portfolio
-
Wellington Management Group LLP Boston, MA3.74MShares$695 Million0.13% of portfolio
-
State Street Corp Boston, MA2.13MShares$396 Million0.02% of portfolio
-
Kayne Anderson Rudnick Investment Management LLC Los Angeles, CA1.94MShares$360 Million0.87% of portfolio
About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
- Ticker CRL
- Exchange NYSE
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 50,863,300
- Market Cap $9.45B
- Description
- Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...